Literature DB >> 1116122

Subcellular fate of protein antibiotic neocarzinostatin in culture of a lymphoid cell line from Burkitt's lymphoma.

H Maeda, S Aikawa, A Yamashita.   

Abstract

14C-LABELED PROTEIN ANTIBIOTIC NEOCARZINOSTATIN (NCS) was prepared efficiently by chemical modification. With the use of lymphoma-derived cell line P3HR-1, the subcellular behavior of this antitumor antibiotic was studied by the uptake a. nd autoradiography of isolated nuclei of radioactive NCS. The antibiotic was taken up by the cells, reaching the maximum value at 1.5 hr and decreasing in value at 4.0 hr to the level at 0.5 hr. The silver grains in the autoradiograms were also found in the isolated nuclei. The grain count in the nuclei showed a tendency similar to the uptake of NCS by the whole cells, i.e., a gradual increase at 0.5 hr, reaching the maximum value at 1.5 hr, and then decreasing after 4.0 hr to the level at 0.5 hr. These facts indicated that NCS reached not only to cytosol but also into the nucleus, and/or at least to the nuclear membrane of the lymphoid cell. The number of NCS molecules incorporated into the cells at 1.5 hr was calculated to be about 1 x 10-6/cells at a concentration of 3 mug NCS per ml of medium, which can be extrapolated to 1 x 10-4 molecules per cell at the minimum inhibitory concentration. The number of molecules should be even less within the nucleus. In cell-free systems, the interaction of DNA and NCS, which is an inhibitor of DNA synthesis, was investigated with use of a Sephadex G-100 column, with negative results. In the cell culture system, NCS molecules were degraded into smaller polypeptides of certain sizes by proteolysis either by serum component(s) or by cells themselves. An inactive isomer, pre-NCS, which is an antagonist of NCS and a partially denatured homologous molecule, behaved similarly to NCS in all of these experiments. Because the chemically modified NCS used in this study retained biological activity essentially similar to that of parental NCS, the results obtained here could be interpreted as similar to those of parental NCS in vitro.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116122

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Fate of antibody-neocarzinostatin conjugates bound to human colonic carcinoma cells in vitro.

Authors:  T Yokota; T Yamaguchi; K Kitamura; T Takahashi
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Regiospecific O-methylation of naphthoic acids catalyzed by NcsB1, an O-methyltransferase involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatin.

Authors:  Yinggang Luo; Shuangjun Lin; Jian Zhang; Heather A Cooke; Steven D Bruner; Ben Shen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

3.  Molecular basis of substrate promiscuity for the SAM-dependent O-methyltransferase NcsB1, involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatin.

Authors:  Heather A Cooke; Elizabeth L Guenther; Yinggang Luo; Ben Shen; Steven D Bruner
Journal:  Biochemistry       Date:  2009-10-13       Impact factor: 3.162

4.  An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.

Authors:  S Sakamoto; H Maeda; J Ogata
Journal:  Experientia       Date:  1979-09-15

5.  Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.

Authors:  H Maeda; S Sakamoto; J Ogata
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

Review 6.  Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

Authors:  Khaled Greish; Jun Fang; Takao Inutsuka; Akinori Nagamitsu; Hiroshi Maeda
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese hamster ovary cells: possible release of nonprotein chromophore in cells.

Authors:  Y Miyamoto; H Maeda
Journal:  Jpn J Cancer Res       Date:  1991-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.